488 results on '"Newson, ainsley J."'
Search Results
2. Liminality between direct and family-mediated contact in the communication of genetic information to at-risk relatives
3. Ethical aspects of the changing landscape for spinal muscular atrophy management in Australia
4. Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia
5. What's in a name? Justifying terminology for genomic findings beyond the initial test indication: A scoping review
6. Preferences for return of germline genome sequencing results for cancer patients and their genetic relatives in a research setting
7. Ethical preparedness in the clinical genomics laboratory: the value of embedded ethics expertise
8. Ethical considerations in gene selection for reproductive carrier screening
9. The promise of public health ethics for precision medicine: the case of newborn preventive genomic sequencing
10. “I wish that there was more info”: characterizing the uncertainty experienced by carriers of pathogenic ATM and/or CHEK2 variants
11. Development and use of the Australian reproductive genetic carrier screening decision aid
12. From ownership to custodianship of tumor biopsy tissue in genomic testing: a mixed methods study of patient views.
13. Impact of personal genomic risk information on melanoma prevention behaviors and psychological outcomes: a randomized controlled trial
14. ‘Integrating Ethics and Equity with Economics and Effectiveness for newborn screening in the genomic age: A qualitative study protocol of stakeholder perspectives
15. Dynamic Consent : An Evaluation and Reporting Framework
16. Family communication about genomic sequencing: A qualitative study with cancer patients and relatives
17. Gene selection for the Australian Reproductive Genetic Carrier Screening Project (“Mackenzie’s Mission”)
18. The Australian landscape of newborn screening in the genomics era
19. What moral weight should patient‐led demand have in clinical decisions about assisted reproductive technologies?
20. Ethically robust reproductive genetic carrier screening needs to measure outcomes that matter to patients
21. Taking seriousness seriously in genomic health
22. Australians’ perspectives on support around use of personal genomic testing: Findings from the Genioz study
23. Acceptability of risk-tailored cancer screening among Australian GPs: a qualitative study.
24. Reconsidering reinterpretation: response to commentaries
25. Hope and Exploitation in Commercial Provision of Assisted Reproductive Technologies
26. Genetic modification
27. Australians’ views and experience of personal genomic testing: survey findings from the Genioz study
28. “Who is watching the watchdog?”: ethical perspectives of sharing health-related data for precision medicine in Singapore
29. Whole genome sequencing in children: ethics, choice and deliberation
30. Genetics and Insurance in Australia : Concerns around a Self-Regulated Industry
31. Acceptability of risk-tailored cancer screening among Australian GPs: a qualitative study
32. Are We Ready for Whole Population Genomic Sequencing of Asymptomatic Newborns?
33. Human Genetics Society of Australasia Position Statement: Genetic Testing and Personal Insurance Products in Australia
34. Human Genetics Society of Australasia Position Statement: Genetic Carrier Testing for Recessive Conditions
35. Is there a duty to routinely reinterpret genomic variant classifications?
36. Is It Just for a Screening Program to Give People All the Information They Want?
37. Implementation considerations for offering personal genomic risk information to the public: a qualitative study
38. Disclosure to genetic relatives without consent – Australian genetic professionals’ awareness of the health privacy law
39. What moral weight should patient‐led demand have in clinical decisions about assisted reproductive technologies?
40. Early Disruption of Centromeric Chromatin Organization in Centromere Protein a (Cenpa) Null Mice
41. Australians’ views on personal genomic testing: focus group findings from the Genioz study
42. Distress, uncertainty, and positive experiences associated with receiving information on personal genomic risk of melanoma
43. Supplementary materials (clean version) from A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public
44. Personalised risk booklet - an example from A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public
45. Human Genetics Society of Australasia Position Statement: Use of Polygenic Scores in Clinical Practice and Population Health
46. Consistency of What? Appropriately Contextualizing Ethical Analysis of Non-Invasive Prenatal Testing
47. Australian Genomics: Outcomes of a 5-year national program to accelerate the integration of genomics in healthcare
48. How should severity be understood in the context of reproductive genetic carrier screening?
49. Are We Ready for Whole Population Genomic Sequencing of Asymptomatic Newborns?
50. Why should ethics approval be required prior to publication of health promotion research?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.